Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects

被引:54
作者
Ramirez, L [1 ]
Braverman, LE [1 ]
White, B [1 ]
Emerson, CH [1 ]
机构
[1] UNIV MASSACHUSETTS, SCH MED, DEPT MED, DIV ENDOCRINOL & METAB, WORCESTER, MA 01655 USA
关键词
D O I
10.1210/jc.82.9.2836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recombinant human TSH (rhTSH) is known to stimulate I-131 uptake and thyroglobulin (Tg) release from the postoperative remnant and metastases in thyroid cancer patients, but its effects on serum thyroid hormone and Tg concentrations in normal subjects have not been reported. Before using rhTSH in the management of thyroid disorders other than cancer, the thyroid response to rhTSH in normal subjects must be assessed. Six subjects, two men and four women, without evidence of thyroid disease, including normal serum free T-4 index and TSH concentrations and negative tests for antithyroid peroxidase and Tg, were studied. Each received 0.1 mg rhTSH, im, 11% of the lowest dose that has been administered to thyroid cancer patients. Blood was obtained before; 2, 4, and 8 h after; and 1, 2, 3, 4, 7, and about 3 weeks after rhTSH administration. Serum TSH significantly increased at 2 h (mean +/- se, 2.4 +/- 0.9 to 40.7 +/- 7.4 mU/mL), peaked at 4 h (50.9 +/- 9.3), remained significantly elevated for 1 day, and was significantly below baseline (0.8 +/- 0.5) 7 days after rhTSH administration. Serum T-3 increased significantly at 4 h (115 +/- 4 to 190 +/- 14 ng/dL), peaked at 24 h (217 +/- 23 ng/dL), and remained significantly elevated for 3 days (151 +/- 12 ng/dL). Serum T-4 increased significantly at 8 h (7.3 +/- 0.2 to 9.8 +/- 0.4 mu g/dL), peaked at 24 h (11.2 +/- 0.5 mu g/dL), and remained significantly elevated for 4 days (9.4 +/- 0.5 mu g/dL). Serum Tg did not change for the first 8 h, increased significantly at 1 day (15.9 +/- 3.9 to 34.7 +/- 6.0 ng/mL), peaked at 2 days (44.2 +/- 7.0 ng/mL), and remained significantly elevated for 4 days (37.7 +/- 13.7 ng/mL). All values returned to baseline at 3 weeks. TSH antibodies were not detected at 3 weeks. A single dose of 0.1 mg rhTSH is a potent stimulator of thyroid function in normal subjects. rhTSH may be a useful agent to test thyroid reserve and for use in clinical settings that require direct thyroid stimulation.
引用
收藏
页码:2836 / 2839
页数:4
相关论文
共 37 条
[1]   DOSIMETRIC DETERMINATION OF I-131 ACTIVITY IN THE TREATMENT OF RECURRENT, NONTOXIC, MULTINODULAR GOITER [J].
BAREIS, CJ ;
BUSHNELL, DL ;
KAUFMAN, GE ;
SPARAGANA, M .
CLINICAL NUCLEAR MEDICINE, 1993, 18 (06) :491-494
[2]  
BENOTTI J, 1965, CLIN CHEM, V11, P932
[3]  
BENUA RS, 1964, J NUCL MED, V5, P796
[4]   RECOMBINANT HUMAN THYROTROPIN STIMULATES THYROID-FUNCTION AND RADIOACTIVE IODINE UPTAKE IN THE RHESUS-MONKEY [J].
BRAVERMAN, LE ;
PRATT, BM ;
EBNER, S ;
LONGCOPE, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) :1135-1139
[5]   IODINE AND THE THYROID - 33 YEARS OF STUDY [J].
BRAVERMAN, LE .
THYROID, 1994, 4 (03) :351-356
[6]  
BRAY GA, 1973, AM J CLIN NUTR, V2, P715
[7]   POTENTIAL EPIDEMIC OF CREUTZFELDT-JAKOB DISEASE FROM HUMAN GROWTH-HORMONE THERAPY [J].
BROWN, P ;
GAJDUSEK, DC ;
GIBBS, CJ ;
ASHER, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) :728-731
[8]   THYROTROPHIN STIMULATION TEST [J].
BURKE, G .
ANNALS OF INTERNAL MEDICINE, 1968, 69 (06) :1127-+
[9]  
EMERSON CH, 1985, MED CLIN N AM S THYR, P1019
[10]  
EMERSON CH, 1997, J CLIN ENDOCR METAB, V82, P9